Search research articles
Contact Us
Filters
Showing results (41-50 of 66) with videos related to
Page
of 7
Sort By:
Melanoma Research
|
May 3, 2026
High dose interleukin-2 in combination with anti-programmed cell death protein 1 to overcome immune checkpoint inhibitor resistance in metastatic melanoma and renal cell carcinoma
Tali Azenkot, Mina Nikanjam, Soham Mhatre, et al.
Antimicrobial Agents and Chemotherapy
|
August 8, 2012
Nevirapine exposure with WHO pediatric weight band dosing: enhanced therapeutic concentrations predicted based on extensive international pharmacokinetic experience
Mina Nikanjam, Desiré Kabamba, Tim R Cressey, et al.
Cancer Medicine
|
December 31, 2025
Inducible T-Cell Co-Stimulator (ICOS) and ICOS Ligand: Dealing With a Two-Faced Cancer Immunoregulatory System
Mina Nikanjam, Shumei Kato, Daisuke Nishizaki, et al.
Biochemical Pharmacology
|
December 9, 2019
Development and preclinical pharmacology of a novel dCK inhibitor, DI-87
Soumya Poddar, Edmund V Capparelli, Ethan W Rosser, et al.
European Journal of Clinical Pharmacology
|
March 23, 2021
S-warfarin limited sampling strategy with a population pharmacokinetic approach to estimate exposure and cytochrome P450 (CYP) 2C9 activity in healthy adults
Lana Tran, Mina Nikanjam, Edmund V Capparelli, et al.
Therapeutic Drug Monitoring
|
January 16, 2023
Fexofenadine Plasma Concentrations to Estimate Systemic Exposure in Healthy Adults Using a Limited Sampling Strategy with a Population Pharmacokinetic Approach
Joseph Piscitelli, Mina Nikanjam, Edmund V Capparelli, et al.
Journal of Clinical Pharmacology
|
September 26, 2018
Population Pharmacokinetics of Lopinavir/Ritonavir: Changes Across Formulations and Human Development From Infancy Through Adulthood
Jincheng Yang, Mina Nikanjam, Brookie M Best, et al.
Molecular Cancer Therapeutics
|
May 25, 2026
GITR and GITR-L RNA Expression Levels Correlate with Better Survival and Response to Immunotherapy
Peter Moussa, Razelle Kurzrock, Daisuke Nishizaki, et al.
Molecular Cancer Therapeutics
|
May 5, 2026
GITR and GITR-L RNA Expression Levels Correlate with Better Survival and Response to Immunotherapy
Peter Moussa, Razelle Kurzrock, Daisuke Nishizaki, et al.
Molecular Oncology
|
September 4, 2020
Clinical implications of plasma circulating tumor DNA in gynecologic cancer patients
Lindsey M Charo, Ramez N Eskander, Ryosuke Okamura, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 66) with videos related to
Sort By:
Page
of 7
Melanoma Research
|
May 3, 2026
High dose interleukin-2 in combination with anti-programmed cell death protein 1 to overcome immune checkpoint inhibitor resistance in metastatic melanoma and renal cell carcinoma
Tali Azenkot, Mina Nikanjam, Soham Mhatre, et al.
Antimicrobial Agents and Chemotherapy
|
August 8, 2012
Nevirapine exposure with WHO pediatric weight band dosing: enhanced therapeutic concentrations predicted based on extensive international pharmacokinetic experience
Mina Nikanjam, Desiré Kabamba, Tim R Cressey, et al.
Cancer Medicine
|
December 31, 2025
Inducible T-Cell Co-Stimulator (ICOS) and ICOS Ligand: Dealing With a Two-Faced Cancer Immunoregulatory System
Mina Nikanjam, Shumei Kato, Daisuke Nishizaki, et al.
Biochemical Pharmacology
|
December 9, 2019
Development and preclinical pharmacology of a novel dCK inhibitor, DI-87
Soumya Poddar, Edmund V Capparelli, Ethan W Rosser, et al.
European Journal of Clinical Pharmacology
|
March 23, 2021
S-warfarin limited sampling strategy with a population pharmacokinetic approach to estimate exposure and cytochrome P450 (CYP) 2C9 activity in healthy adults
Lana Tran, Mina Nikanjam, Edmund V Capparelli, et al.
Therapeutic Drug Monitoring
|
January 16, 2023
Fexofenadine Plasma Concentrations to Estimate Systemic Exposure in Healthy Adults Using a Limited Sampling Strategy with a Population Pharmacokinetic Approach
Joseph Piscitelli, Mina Nikanjam, Edmund V Capparelli, et al.
Journal of Clinical Pharmacology
|
September 26, 2018
Population Pharmacokinetics of Lopinavir/Ritonavir: Changes Across Formulations and Human Development From Infancy Through Adulthood
Jincheng Yang, Mina Nikanjam, Brookie M Best, et al.
Molecular Cancer Therapeutics
|
May 25, 2026
GITR and GITR-L RNA Expression Levels Correlate with Better Survival and Response to Immunotherapy
Peter Moussa, Razelle Kurzrock, Daisuke Nishizaki, et al.
Molecular Cancer Therapeutics
|
May 5, 2026
GITR and GITR-L RNA Expression Levels Correlate with Better Survival and Response to Immunotherapy
Peter Moussa, Razelle Kurzrock, Daisuke Nishizaki, et al.
Molecular Oncology
|
September 4, 2020
Clinical implications of plasma circulating tumor DNA in gynecologic cancer patients
Lindsey M Charo, Ramez N Eskander, Ryosuke Okamura, et al.
Page
of 7